Karlygash N Tazhibayeva¹*, Galiya E Kaldygozova², Almas N Ormanov³, Assel D Sadykova⁴, Bolat B Daurenov⁵, Alizada F Kuliev5 and Aiman A Mussina⁶

¹Assistant-Professor, Shymkent City Cancer Center, Khoja Akhmet Yassawi International Kazakh-Turkish University, Al-Farabi Kazakh National University, Kazakhstan
²Assistant-Professor, Candidate of Medical Sciences, Al-Farabi Kazakh National University, Khoja Akhmet Yassawi International Kazakh-Turkish University, Kazakhstan
³Khoja Akhmet Yassawi International Kazakh-Turkish University, Kazakhstan
⁴Assistant-Professor, Al-Farabi Kazakh National University, Kazakhstan
⁵Candidate of Medical Sciences, Khoja Akhmet Yassawi International Kazakh-Turkish University, Kazakhstan
⁶Candidate of Medical Sciences, NJSC Astana Medical University, Kazakhstan

*Corresponding Author: Karlygash N Tazhibayeva, Assistant-Professor, Shymkent City Cancer Center, Khoja Akhmet Yassawi International Kazakh-Turkish University, Al-Farabi Kazakh National University, Kazakhstan.

Received: November 08, 2022; Published: March 14, 2023

Abstract

The purpose of the study is to substantiate the need for a comprehensive program for the early detection of malignant manifestations of visual localization, to develop, implement and evaluate its effectiveness.

Keywords: Epidemiology; Cancer; Working-Age

References

1. 261 dated January 30, 2012 "The program for the development of cancer care in the Republic of Kazakhstan for 2012-2016" was approved by the decree of the President of the Republic of Kazakhstan”. Astana (2012).
2. State program "Health" for the years 2016-2019 of health care development by the Decree of the President of the Republic of Kazakhstan”. Astana (2021).
3. State program "Healthy Kazakhstan" for 2011-2015 for the development of the healthcare sector of the Republic of Kazakhstan, approved by the decree of the President of the Republic of Kazakhstan No. 1113 of November 29, 2010”. Astana (2020).
4. Alieva TM. “Screening for cervical cancer. Mistakes in diagnosis and ways to prevent them”. International Congress Health for All. - Almaty (2021): 24-27.
5. Ferlay J., et al. “GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide IARC Cancerbase”. International Agency for Research on Cancer (2021).
6. 145 dated March 16, 2011 On amendments to the order of the Minister of Health of the Republic of Kazakhstan “On approval: Rules for conducting preventive medical examinations of target population groups”. 2 (2011).
7. Kaidarov BK., et al. “The incidence of colorectal cancer and the state of surgical care for oncological patients with this pathology”. Oncology and Radiology of Kazakhstan 4 (2011): 37-40.
8. Boyle P and Levin B. “World Cancer Report 2010. International Agency for Research on Cancer (IARC)”. Geneva (2010): 1-6.
9. Alanbay I., et al. “The cytohistological discrepencies of cervicovaginal smears and hpv status”. ESGO eAcademy Alanbayi 24 (2015): 107-109.
10. Oberaigner W., et al. “Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol Austria”. Breast 33 (2021): 178-182.
11. Autier P., et al. “Breast cancer mortality in neighbouring European countries with different levels of screening”. Trend Analysis of WHO. BMJ 28 (2011): 343-4411.
12. Gnerlich JL., et al. “Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease”. Journal of the American College of Surgeons 21 (2009): 341-347.
13. Deshpande AD., et al. “Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration”. Annals of Surgical Oncology 7 (2021): 1837-1844.
14. Haifa Dbouk., et al. “Epidemiology and prognosis of breast cancer in young women”. Journal of Thoracic Disease 5 (2013): 2-8.
15. Andrae B., et al. “Screening-preventable cervical cancer risk: a national audit data in Sweden”. Journal of the National Cancer Institute 100 (2018): 622-629.
16. Andriole GL., et al. “Mortality results from a randomized prostate-cancer screening trial”. The New England Journal of Medicine 360 (2021): 1310-1319.
17. Bretthauer M and Kalager M. “Priciples effectiveness and caveats in screening for cancer”. British Journal of Surgery 100 (2014): 55-65.
18. Brenner H., et al. “Breast Cancer Estimated Incidence. Mortality and Prevalence Worldwide in 2012”. GLOBOCAN 2012 (IARC), Section of Cancer Surveillance (2017). https://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp.
19. Ferlay J., et al. “GLOBOCAN Cancer Incidence and Mortality Worldwide: IARC CancerBase. -Lyon; France: International Agency for Research on Cancer 1.11 (2021).
20. Komarova LE. “The current state of screening programs in oncology FGBU”. Russian Journal of Oncology 5 (2013): 48-51.
21. Poddubnaya IV., et al. “Epidemiological program for screening HER2 status in patients with breast cancer: results of 2014”. Journal of Modern Oncology 3 (2015): 108-118.
22. Kaprin AD., et al. “Malignant neoplasms in Russia in 2012 (morbidity and mortality). M.: FGBU “MNIOI im. P. A. Herzen” of the Ministry of Health of Russia (2014): 250.
23. Navruzov SN., et al. “Mammary cancer. Problems of early diagnosis and prevention: guidelines. Tashkent (2013).
24. Khudaikulov AT and Khudaikulov TK. “Socio-economic consequences of women's mortality frm breast cancer in Uzbekistan”. Malignant tumors 1 (2021): 53-56.
25. Mahshid Ghoncheh., et al. “Epidemiology, Incidence and Mortality of Breast Cancer in Asi. Epidemiology”. Incidence and Mortality of Breast Cancer in Asia 17 (2016): 47-52.
26. By Jennifer S., et al. “Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement”. American Medical Association. JAMA23 (2021): 2564-2575.
27. Samson Okello., et al. “Population attributable fraction of Esophageal squamous cell carcinoma due to smoking and alcohol in Uganda. Corey”. BMC Cancer 16 (2021): 1-6.
28. Tseng TS., et al. “Who tended to continue smoking after cancer diagnosis”. BMC Public Health 12 (2012): 784.

Citation

Citation: Karlygash N Tazhibayeva., et al. “Epidemiology of Visual Cancer and Determination of the Incidence in the Working-Age Population". Acta Scientific Neurology 6.4 (2023): 28-39.

Copyright

Copyright: © 2023 Karlygash N Tazhibayeva., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.